Business Context and Reporting Period
Company: Frequency Electronics, Inc. (FEIM)
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Three and six months ended October 31, 2024
Business Overview: The Company operates in two segments: FEI-NY (precision time and frequency control products for satellites, terrestrial telecom, and military) and FEI-Zyfer (GPS technologies for secure communications and wireline telecom). The Company is a non-accelerated filer and smaller reporting company.
Key Financial Metrics
| Metric | Three Months Ended Oct 31, 2024 | Six Months Ended Oct 31, 2024 |
|---|---|---|
| Revenues | $15.82 million | $30.90 million |
| Gross Margin | $7.62 million (48.2%) | $14.32 million (46.3%) |
| Operating Income | $2.62 million (16.6%) | $4.98 million (16.1%) |
| Net Income | $2.65 million | $5.08 million |
| Diluted EPS | $0.28 | $0.53 |
| Cash and Equivalents | $9.70 million (Oct 31, 2024) | N/A |
| Working Capital | $23.44 million (Oct 31, 2024) | N/A |
| Funded Backlog | $81.0 million (Oct 31, 2024) | N/A |
Liquidity: The Company reported a current ratio of 1.8 to 1 as of October 31, 2024. Net cash provided by operating activities for the six months ended October 31, 2024, was $2.35 million.
Material Changes vs. Prior Period
- Revenue Growth: Consolidated revenues increased 16.5% year-over-year for the quarter and 18.9% for the six-month period. This was driven primarily by a $3.8 million increase in sales to U.S. Government space customers within the FEI-NY segment.
- Margin Expansion: Gross margin rate improved significantly to 48.2% (Q2) and 46.3% (YTD) compared to 31.9% and 35.4% in the prior year periods. This was attributed to a large space program completing a major production milestone, mitigating risk and releasing costs.
- Expense Increases: Selling, General, and Administrative (SG&A) expenses rose 32.8% (Q2) and 28.4% (YTD) due to payroll increases, employee re-alignment, and costs associated with the "Quantum Summit." Research and Development (R&D) expenses surged 92.0% (Q2) and 130.2% (YTD) to focus on product modernization.
- Dividend Payment: The Company paid a special cash dividend of $1.00 per share totaling approximately $9.6 million in August 2024, resulting in a net decrease in cash and cash equivalents.
Outlook, Risks, and Unusual Items
- Internal Control Material Weakness: Management identified a material weakness in internal control over financial reporting regarding the calculation of loss provision accruals in contracts with customers. While errors were corrected prior to the April 30, 2024 filing, the weakness persisted as of October 31, 2024. Remediation efforts are underway.
- Geopolitical Risk (Morion, Inc.): The Company terminated all commercial relationships with Morion, Inc., a Russian supplier, following its designation as a Specially Designated National by the U.S. Treasury on October 30, 2024. The Company has established alternate supply sources and can fabricate necessary crystal blanks in-house.
- Tax Position: The Company maintains a full valuation allowance against its deferred tax assets. However, management notes it is reasonably possible this allowance will be reduced within the next 12 months.
- Backlog: Funded backlog increased to approximately $81 million, with 65% expected to be realized in the next twelve months.
Investor Verification Checklist
- Remediation Progress: Verify the status of the remediation plan for the material weakness in loss provision accruals and its impact on future financial reporting reliability.
- Supply Chain Resilience: Confirm the operational stability and cost implications of replacing Morion, Inc. as a supplier for quartz crystal blanks.
- Revenue Sustainability: Assess the durability of the revenue growth driven by the specific U.S. Government space program milestone and whether similar margin expansion is sustainable.
- Cash Flow vs. Dividends: Evaluate the impact of the $9.6 million special dividend on future liquidity and capital allocation strategies, given the reduction in cash reserves.
- R&D ROI: Monitor the return on the significant increase in R&D spending to ensure it translates into future contract awards and product competitiveness.